Syneos Health and Aetion Partner to Offer RWE Solutions to Advance Drug Development and Commercialization
August 02, 2021 07:00 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C. and NEW YORK, Aug. 02, 2021 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH) and Aetion® announced a partnership to provide regulatory-grade data and analytics-driven solutions to...
Syneos Health Launches “Lab to Life” Enterprise Partnership with Komodo Health
May 03, 2021 07:00 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., May 03, 2021 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, announced today it has expanded its relationship...
Syneos Health Partners with Medable, Expanding Decentralized Solutions to Bring Clinical Trials Closer to the Patient
April 20, 2021 09:00 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C. and PALO ALTO, Calif., April 20, 2021 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, and Medable, the leading...
Real-world Evidence (RWE) Solutions Market to Reach $3.13 Billion by 2027, Growing at a CAGR of 16.5%, Says Meticulous Research®
March 15, 2021 08:30 ET
|
Meticulous Market Research Pvt. Ltd.
Redding, California, March 15, 2021 (GLOBE NEWSWIRE) -- According to a new market research report, “Real-world Evidence (RWE) Solutions Market by Component [Datasets, EMR, Services], Application...
The real world evidence (RWE) market is projected to be worth USD 4.5 billion by 2030, growing at a CAGR of 15%, claims Roots Analysis
March 03, 2021 08:45 ET
|
Roots Analysis
London, March 03, 2021 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of “Pharmaceutical and Life Sciences Real World Evidence Market, (2nd Edition), 2021-2030” report to its list of...
Real-World Evidence (RWE) Solutions Market Worth $3.13 billion by 2027- Exclusive Report Covering Pre and Post COVID-19 Market Analysis by Meticulous Research®
November 25, 2020 08:30 ET
|
Meticulous Market Research Pvt. Ltd.
London, Nov. 25, 2020 (GLOBE NEWSWIRE) -- According to a new market research report “Real-World Evidence (RWE) Solutions Market by Component [Datasets, EMR, Services], Application [Drug Development...
Alliance for Regenerative Medicine Calls for Multi-Stakeholder Pan-European Initiative to Fast-Track Real World Evidence in Support of Patient Access to Advanced Therapies
July 29, 2020 02:00 ET
|
The Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Calls for Multi-Stakeholder Pan-European Initiative to Fast-Track Real World Evidence in Support of Patient Access to Advanced Therapies BRUSSELS, BELGIUM. – July...
Syneos Health Releases Report Identifying Barriers to Payer Use of RWE in Rare Disease and Recommendations for Advancing Payer Engagement
November 21, 2019 09:02 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C. and NEW YORK , Nov. 21, 2019 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today released “Real World Value:...
Evidation Health to Present at ISPOR 2017 on the Real Life Behavioral Factors Associated with Quality of Life
May 22, 2017 07:00 ET
|
Evidation Health, Inc.
San Mateo, CA, May 22, 2017 (GLOBE NEWSWIRE) -- Evidation Health today announces the results from a study examining the association between behavioral traits inferred from passive trackers and...
61% of Interventional Studies Are Traditional Randomized Control Trails
June 28, 2016 08:17 ET
|
Cutting Edge Information
RESEARCH TRIANGLE PARK, NC--(Marketwired - June 28, 2016) - A new study published by Cutting Edge Information discovered that 61% of interventional studies are traditional randomized control trials...